Evaluation of Kidney Disease in Liver Transplant Recipients
| Status: | Withdrawn |
|---|---|
| Conditions: | Renal Impairment / Chronic Kidney Disease |
| Therapuetic Areas: | Nephrology / Urology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/21/2016 |
| Start Date: | September 2006 |
Kidney Disease in Advanced Liver Disease Patients: A Study of Kidney Damage by a Urinary Cytokine/Chemokine Multiplex Assay
A non-invasive urinary test that detects kidney injuries in liver transplant (LT) candidates
would be useful for monitoring of kidney damage. Particularly, the ability to predict
irreversibility of such renal damage or progressive nature of renal disease in LT candidates
would be of importance to determine the need for dual kidney-liver transplantation (KLT)
versus LT alone. We will correlate kidney histology with cytokine/chemokine profile
expression in the urine as a potentially useful noninvasive diagnostic tool.
would be useful for monitoring of kidney damage. Particularly, the ability to predict
irreversibility of such renal damage or progressive nature of renal disease in LT candidates
would be of importance to determine the need for dual kidney-liver transplantation (KLT)
versus LT alone. We will correlate kidney histology with cytokine/chemokine profile
expression in the urine as a potentially useful noninvasive diagnostic tool.
Inclusion Criteria:
- Subjects on the liver transplant wait list, subjects who have received a liver
transplant at least 6 months prior to enrollment, or subjects who have normal liver
function and are about to undergo kidney biospy for diagnostic purposes.
Exclusion Criteria:
- Contraindication to kidney biopsy
- Inability to give informed consent
We found this trial at
1
site
University of Wisconsin In achievement and prestige, the University of Wisconsin–Madison has long been recognized...
Click here to add this to my saved trials
